MeSH term
Frequency | Condition_Probility | Animals | 23 | 0.0 |
Gene Expression | 6 | 0.0 |
Humans | 79 | 0.0 |
Aged | 7 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Comparative Study | 12 | 0.0 |
Female | 33 | 0.0 |
Male | 33 | 0.0 |
Middle Aged | 10 | 0.0 |
Prospective Studies | 2 | 0.0 |
Treatment Outcome | 4 | 0.0 |
Fibroblasts/enzymology | 2 | 1.0 |
Fluorometry | 2 | 2.0 |
Lysosomes/enzymology | 2 | 3.0 |
Mucopolysaccharidosis II/*diagnosis/*enzymology | 2 | 100.0 |
*Helix-Loop-Helix Motifs | 2 | 2.0 |
RNA, Messenger/metabolism | 4 | 0.0 |
*Repressor Proteins | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 51 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 14 | 0.0 |
COS Cells | 4 | 0.0 |
Mucopolysaccharidosis II/enzymology/*genetics | 4 | 80.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
Mutation | 5 | 0.0 |
Transfection | 6 | 0.0 |
Adult | 10 | 0.0 |
Child, Preschool | 5 | 0.0 |
Infant | 4 | 0.0 |
Phenotype | 9 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Amino Acid Sequence | 6 | 0.0 |
Base Sequence | 18 | 0.0 |
Iduronate Sulfatase/*genetics | 20 | 90.0 |
Mice | 10 | 0.0 |
Molecular Sequence Data | 18 | 0.0 |
Cells, Cultured | 7 | 0.0 |
Coculture Techniques | 2 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Glycosaminoglycans/metabolism | 2 | 4.0 |
Iduronate Sulfatase/*genetics/metabolism | 2 | 100.0 |
Mucopolysaccharidosis II/blood | 2 | 100.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
*Bone Marrow Transplantation | 2 | 0.0 |
Child | 8 | 0.0 |
Linkage (Genetics) | 9 | 0.0 |
Polymorphism, Genetic | 5 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
X Chromosome/*genetics | 4 | 1.0 |
Mutation/*genetics | 2 | 0.0 |
DNA Mutational Analysis | 9 | 0.0 |
English Abstract | 3 | 0.0 |
Pregnancy | 6 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Exons | 8 | 0.0 |
Mucopolysaccharidosis II/enzymology/genetics | 4 | 80.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
*Mutation | 7 | 0.0 |
Gene Deletion | 2 | 0.0 |
Genotype | 4 | 0.0 |
Mucopolysaccharidosis II/genetics | 5 | 83.0 |
Mutation, Missense | 2 | 0.0 |
Italy | 2 | 0.0 |
Restriction Mapping | 5 | 0.0 |
Introns | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
X Chromosome/genetics | 2 | 1.0 |
Adolescent | 5 | 0.0 |
DNA Primers | 4 | 0.0 |
Mucopolysaccharidosis II/*genetics | 9 | 81.0 |
Chromosome Mapping | 8 | 0.0 |
Recombination, Genetic | 3 | 0.0 |
Iduronate Sulfatase/deficiency/*genetics | 6 | 100.0 |
Pedigree | 8 | 0.0 |
Rats | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Glycosylation | 2 | 0.0 |
Endocytosis | 2 | 0.0 |
Dosage Compensation (Genetics) | 3 | 2.0 |
Genetic Markers | 6 | 0.0 |
Heterozygote | 4 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
*Linkage (Genetics) | 3 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
Genomic Library | 2 | 0.0 |
*X Chromosome | 11 | 1.0 |
Immunoglobulin Idiotypes/*immunology | 2 | 5.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
*Gene Therapy | 2 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Gene Rearrangement | 4 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
*Genes, Structural | 2 | 0.0 |
DNA | 3 | 0.0 |
Prenatal Diagnosis | 2 | 1.0 |
Blotting, Southern | 10 | 0.0 |
DNA Probes | 4 | 0.0 |
DNA Restriction Enzymes | 2 | 0.0 |
*Heterozygote Detection | 3 | 2.0 |
Polymorphism, Restriction Fragment Length | 7 | 0.0 |
Iduronate Sulfatase/genetics | 4 | 80.0 |
Variation (Genetics) | 2 | 0.0 |
X Chromosome | 8 | 1.0 |
Genome, Human | 3 | 0.0 |
Species Specificity | 2 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Retrospective Studies | 3 | 0.0 |
*Chromosome Deletion | 5 | 0.0 |
Chromosomes, Fungal | 2 | 3.0 |
Fragile X Syndrome/*genetics | 3 | 1.0 |
Cell Line | 3 | 0.0 |
Hamsters | 2 | 0.0 |
*Mucopolysaccharidosis II/enzymology/*genetics | 2 | 100.0 |
*DNA Probes | 2 | 4.0 |
*DNA Replication | 2 | 0.0 |
In Vitro | 2 | 0.0 |
